This content is for informational purposes only. It is not medical advice and it is not dosing guidance. Never change your dose, split doses, or alter your schedule without direction from your prescribing provider. Follow the instructions from your provider and your medication’s labeling.
In This Guide
- Understanding how GLP-1 titration works
- What providers consider before a dose change
- Medical supervision is not optional
- Preparing for a conversation about your dose
- What to expect after a dose increase
- Compounded versus FDA-approved GLP-1 medications
- When staying at your current dose is the right call
- If a dose is missed or delayed
- Longer-term planning
Key Takeaways
Q: Why does treatment start at a low dose? A: Starting low and increasing gradually is intended to improve tolerability, since gastrointestinal side effects are most common when beginning treatment and after each increase.
Q: When might a provider consider a higher dose? A: Providers weigh a range of factors, including how your treatment is progressing, how well you are tolerating the current dose, and your overall clinical picture.
Q: Are titration timelines fixed? A: Approved dosing schedules differ by medication and are set out in each product’s labeling. Within that framework, providers such as those at LevelsRx individualize timing based on how a patient is responding.
Q: Does the medication format affect dosing? A: Yes. Approved products come in defined strengths set by the manufacturer and reviewed by the FDA. Compounded formulations are not FDA-approved and are prepared differently — see the section below.
Q: Should I always increase if I am tolerating the dose well? A: Not necessarily. Tolerating a dose is not on its own a reason to increase it. Many patients do well remaining at a lower effective dose, and that is a decision for your provider.
Q: Can I skip a step to speed up progress? A: No. Do not alter your prescribed schedule. Escalating faster than prescribed increases the risk of significant gastrointestinal reactions and dehydration.
GLP-1 medications require a prescription from a licensed healthcare provider. Eligibility and dosing are determined on a case-by-case basis.
Understanding how GLP-1 titration works
Titration means starting at a low dose and increasing in steps over weeks or months. The purpose is to give the body time to adapt, which is intended to improve tolerability — though it does not prevent side effects for everyone.
Why step-up dosing is used
- Receptor adaptation: Gradual exposure to increased receptor activation is intended to reduce the intensity of gastrointestinal reactions.
- Digestive adjustment: Stepwise changes allow the digestive system to adapt to slowed gastric emptying more gradually.
- Clinical monitoring: Each step gives the provider an opportunity to assess response before going further.
Providers, including the teams at LevelsRx, use this approach to balance treatment goals against day-to-day tolerability. Escalating faster than prescribed is associated with more severe adverse reactions.
| Treatment Phase | General Purpose |
| Initiation | Introduce the medication and assess baseline tolerance |
| Titration | Step the dose up according to the schedule in the product’s labeling |
| Maintenance | Continue at the dose your provider determines is appropriate long term |
This table describes the general shape of treatment, not a schedule to follow. Approved dose strengths, intervals, and maximum doses differ between medications and are specified in each product’s FDA-approved labeling.
Important safety information. GLP-1 receptor agonists such as semaglutide, tirzepatide, and orforglipron carry an FDA boxed warning regarding the risk of thyroid C-cell tumors. In rodent studies, medications in this class have caused thyroid C-cell tumors; the human relevance has not been determined. These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other serious risks include acute pancreatitis, acute gallbladder disease, severe gastrointestinal reactions, and serious hypersensitivity reactions including anaphylaxis. Seek immediate medical attention for severe abdominal pain that may radiate to the back.
What providers consider before a dose change
Providers assess a combination of clinical factors rather than any single trigger. Commonly discussed considerations include:
- Treatment response: How your progress compares with what was expected at the current dose.
- Appetite and symptom changes: Shifts in appetite or a return of preoccupation with food are things providers ask about.
- Tolerability: Whether current side effects are settled enough that an increase is reasonable.
- Overall clinical picture: Other conditions, current medications, and relevant lab results.
Tolerating a dose without side effects is not by itself an indication to increase. Whether an increase is appropriate depends on the full picture, and only your provider can weigh it.
Medical supervision is not optional
A dose adjustment should never happen without your prescriber. Changing a prescription independently can cause significant gastrointestinal reactions and dehydration.
A typical review might involve:
- Reviewing your logs covering food intake, hydration, and side effects.
- Looking at trends over a meaningful period rather than a single measurement.
- Discussing physical comfort, sleep, and energy levels.
- Issuing an updated prescription if clinically indicated.
Preparing for a conversation about your dose
Keeping a simple record makes these conversations more productive, because your provider is relying on what you report between appointments.
- Note your weight on a consistent schedule, at the same time of day, to distinguish trends from normal daily fluctuation.
- Keep a general record of your eating patterns and whether you are managing adequate nutrition — particularly protein — at your current appetite level.
- Note changes in appetite and how you are feeling day to day.
- Document any discomfort, including when it occurs relative to doses and meals.
If reduced appetite is making it difficult to eat enough, say so. That is important clinical information, and under-eating is something your provider will want to address rather than something to push through.
What to expect after a dose increase
Stepping up introduces a period of adjustment. Common experiences in the days following an increase include:
- Reduced appetite: You may feel full after smaller portions, which makes nutrient-dense choices and adequate protein more important.
- Fatigue: Some patients report temporary tiredness during adjustment.
- Digestive changes: A temporary return of nausea, reflux, or constipation is frequently reported after an increase.
Measures that may help during the transition
- Pay attention to hydration in the days around a dose change.
- Favour lean proteins and go easy on high-fat, fried, or heavily processed foods.
- Spread intake across several smaller meals rather than a few large ones.
- Contact your LevelsRx care team if symptoms persist beyond a few days or become difficult to manage.
Contact your provider promptly — the same day — if you cannot keep fluids down. Seek emergency care for severe abdominal pain, particularly pain radiating to the back, or signs of an allergic reaction.
Compounded versus FDA-approved GLP-1 medications
Compounded medications are not FDA-approved and have not been evaluated for safety, efficacy, or quality by the FDA. A compounded preparation is a customized formulation prepared by a compounding pharmacy and prescribed by a licensed provider based on individual patient needs. It is not a generic version of, nor equivalent to, an FDA-approved product, and the clinical trial results published for approved medications do not transfer to compounded preparations.
Patients often ask how the two differ in practice.
| FDA-Approved Products | Compounded Preparations | |
| Regulatory status | Reviewed and approved by the FDA for specific indications | Not FDA-approved; not evaluated by the FDA for safety, efficacy, or quality |
| Dosing | Defined strengths and schedules set out in FDA-approved labeling | Determined by the prescriber and the compounding pharmacy |
| Delivery | Typically pre-filled, fixed-dose pens | Typically vials administered with a syringe |
| Evidence base | Supported by the manufacturer’s clinical trial programme | No equivalent trial programme |
Because compounded preparations do not carry FDA-approved labeling, there is no approved dosing schedule for them, and any regimen is at the discretion of the prescriber. Dosing approaches sometimes discussed in connection with compounded products — including fractional dosing or dividing a weekly amount across multiple administrations — have not been evaluated or approved by the FDA. Do not attempt any such approach on your own, and discuss the regulatory status and what is known about safety and quality with your provider before starting any compounded medication.
When staying at your current dose is the right call
A higher dose is not automatically a better one. There are many situations where remaining where you are is the sounder clinical decision, including when treatment is progressing steadily at the current level, when relevant clinical markers are where your provider wants them, or when side effects are settling but need more time.
The lowest effective dose
Many providers aim to find and maintain the lowest dose that achieves the clinical goal, for as long as that dose remains appropriate. The reasoning generally offered is that this approach:
- Limits unnecessary exposure and reduces the likelihood of adverse reactions.
- Preserves options should an adjustment be needed later.
- Keeps the treatment experience manageable over the longer term.
Whether this approach suits you is a clinical judgment, not a rule.
If a dose is missed or delayed
Instructions for a missed dose differ between medications and are specified in each product’s labeling. Follow your product’s labeling and your provider’s instructions rather than general guidance from any article.
- Contact your LevelsRx provider before taking your next dose if you have missed one, particularly if a significant gap has passed.
- Do not double up to compensate for a missed dose.
- Do not resume at your previous dose after an extended gap without checking first — restarting at a lower dose is sometimes necessary, and that is a clinical decision.
- Always prioritize direct instructions from your provider over general online advice.
Longer-term planning
As treatment progresses, the focus shifts toward sustainable, long-term management. Both currently approved oral GLP-1 medications for weight management are indicated to reduce excess body weight and maintain weight reduction long term, and weight regain commonly follows discontinuation of GLP-1 therapy. Long-term planning is therefore part of the conversation from the start, not an afterthought.
Discussing the maintenance phase
If and when your provider considers a transition toward maintenance, that discussion typically covers:
- Dosing going forward: Whether and how the regimen changes is determined by your prescriber within the approved labeling for your medication. Extending intervals between doses beyond what the labeling specifies is not an approved regimen and should not be attempted independently.
- Lifestyle foundations: Established dietary habits, adequate protein intake, and resistance training are consistently emphasized for preserving lean muscle mass.
- Ongoing monitoring: Periodic review and lab work as directed by your provider.
- What stopping would involve: Worth raising explicitly, including the likelihood of weight regain.
Sustained results rely on continued, honest communication with your care team. By following your prescribed schedule, reporting symptoms as they arise, and raising questions before acting on them, you keep your treatment plan matched to what your body is actually doing.
This content is for informational purposes only and does not constitute medical advice or dosing guidance. GLP-1 medications require a prescription from a licensed healthcare provider, and dosing is determined on a case-by-case basis. Compounded medications are not FDA-approved and have not been evaluated for safety, efficacy, or quality by the FDA. Individual results vary and depend on diet, exercise, medical history, and adherence to treatment.
